Your browser doesn't support javascript.
loading
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng, Kevin W; Boumelha, Jesse; Enfield, Katey S S; Almagro, Jorge; Cha, Hongui; Pich, Oriol; Karasaki, Takahiro; Moore, David A; Salgado, Roberto; Sivakumar, Monica; Young, George; Molina-Arcas, Miriam; de Carné Trécesson, Sophie; Anastasiou, Panayiotis; Fendler, Annika; Au, Lewis; Shepherd, Scott T C; Martínez-Ruiz, Carlos; Puttick, Clare; Black, James R M; Watkins, Thomas B K; Kim, Hyemin; Shim, Seohee; Faulkner, Nikhil; Attig, Jan; Veeriah, Selvaraju; Magno, Neil; Ward, Sophia; Frankell, Alexander M; Al Bakir, Maise; Lim, Emilia L; Hill, Mark S; Wilson, Gareth A; Cook, Daniel E; Birkbak, Nicolai J; Behrens, Axel; Yousaf, Nadia; Popat, Sanjay; Hackshaw, Allan; Hiley, Crispin T; Litchfield, Kevin; McGranahan, Nicholas; Jamal-Hanjani, Mariam; Larkin, James; Lee, Se-Hoon; Turajlic, Samra; Swanton, Charles; Downward, Julian; Kassiotis, George.
Afiliação
  • Ng KW; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
  • Boumelha J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.
  • Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Almagro J; Adult Stem Cell Laboratory, The Francis Crick Institute, London, UK.
  • Cha H; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Pich O; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Salgado R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Sivakumar M; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
  • Young G; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Molina-Arcas M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • de Carné Trécesson S; Department of Cellular Pathology, University College London Hospitals, London, UK.
  • Anastasiou P; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.
  • Fendler A; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Queensland, Australia.
  • Au L; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Shepherd STC; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
  • Martínez-Ruiz C; Bioinformatics and Biostatistics Facility, The Francis Crick Institute, London, UK.
  • Puttick C; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.
  • Black JRM; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.
  • Watkins TBK; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.
  • Kim H; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Shim S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Faulkner N; Renal and Skin Units, The Royal Marsden Hospital, London, UK.
  • Attig J; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Veeriah S; Renal and Skin Units, The Royal Marsden Hospital, London, UK.
  • Magno N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Ward S; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Lim EL; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Hill MS; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Wilson GA; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Birkbak NJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Behrens A; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
  • Yousaf N; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
  • Popat S; National Heart and Lung Institute, Imperial College London, London, UK.
  • Hackshaw A; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
  • Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • McGranahan N; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
  • Jamal-Hanjani M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Larkin J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Lee SH; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Turajlic S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Downward J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Kassiotis G; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Nature ; 616(7957): 563-573, 2023 04.
Article em En | MEDLINE | ID: mdl-37046094
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retrovirus Endógenos / Imunoterapia / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retrovirus Endógenos / Imunoterapia / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article